![Heiko von der Leyen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Heiko von der Leyen is currently the Medical Director at Orgenesis, Inc. He previously worked as the Managing Director at Hannover Clinical Trial Center GmbH from 2005 to 2017.
Prior to that, he was the Medical Director & VP-Clinical Development at Cardion GmbH from 1998 to 2001.
He also served as the Chief Scientific Officer at Avontec GmbH in 2003 and at Artiss GmbH in 2001-2002.
Posizioni attive di Heiko von der Leyen
| Società | Posizione | Inizio |
|---|---|---|
| ORGENESIS INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2020 |
Precedenti posizioni note di Heiko von der Leyen
| Società | Posizione | Fine |
|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01/01/2017 |
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Artiss GmbH | Direttore Tecnico/Scientifico/R&S | 01/01/2002 |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Direttore Tecnico/Scientifico/R&S | 01/01/2001 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Orgenesis, Inc.
 Orgenesis, Inc. Operates as a development stage company, which focuses on treatment of diabetes. | |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Health Technology |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Hannover Clinical Trial Center GmbH | |
Artiss GmbH |
